Drug Device Combination Products Market Analysis
Pharmaceutical-combination products are therapeutic and diagnostic products, counting drug and medical devices. Prefilled syringes, drug coated equipment and co-packages are just a few examples of traditional drug/device combination products.
Global Drug Device Combination Products Market: Drivers
The growing rate of chronic disorders like cancer, heart disorder, disseminated sclerosis and diabetes may be a key aspect driving market growth. In 2017, as per the National Center for Biotechnology Information (NCBI), 2020, over 126 million people worldwide affected from chlorosis heart disorder (1,655/100,000), considering 1.72% of the entire world population.
Furthermore, the growing elder public is probably going to assist the market grow. for example, as per the U.S. Census Bureau, by 2034 the U.S. elder public is probably going to succeed in 77 million.
The size of the global drug device combination products market is estimated to be accounted at US$ 123.5 billion and over the estimated period (2020-2027) it’s likely to witness a CAGR of 8.2%.
𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 @ https://www.coherentmarketinsights.com/insight/request-sample/3919
Global Drug Device Combination Products Market: Restraints
Drug device combination products drive the danger of infection, which obstructs market growth. However, stent infection is rare, it’s related to high mortality and morbidity. Drug eluting stents (DES) are related to higher risk of infection than bare metal stents (BMS), because of their antiproliferative effect.
Growing product recalls are likely to curb the expansion of the world pharmaceutical-device combination products market over the estimated period. as an example, Perigo Company plc, a developer of self-care products, cancelled Albuterol Sulfate Inhaler manufactured by Catalant Pharma Solutions in September 2020 for Perrigo company. Albuterol sulfate inhalation aerosol is specified for the therapy of bronchospasm or for the prevention of recurrent difficult airway disorder and for the prevention of exercise convinced bronchospasm. But, recently, Perigo has received objections that patients aren’t getting enough or no medication because the inhaler has stopped.
Furthermore, the presence of strict and general regulatory pathways for permission of drug device combination products is additionally likely to obstruct market growth. The U.S. Investigative New Drug (IND) has separate regulatory permissions for pharmaceutical products and medical devices, the applying process for pharmaceutical products is fair, while medical devices fall into the Inspection Equipment Suite (IDE) route.
Global Drug Device Combination Products Market: Opportunities
The adoption of cloud-based data management software together products is probably going to produce beneficial growth opportunities for players within the global drug-device combination products market. For exampleMedtronic plc introduced cloud-based data management software Efficio in January 2020 to be used with the SynchroMed II intrathecal drug delivery system for efficient management of targeted drug delivery pumps.
Moreover, the launch of generic combination products is probably going to assist the market growth. As an example, Teva Pharmaceutical Industries Ltd introduced a generic version of Mylan’s EpiPen for young children in August 2019.
Global Drug Device Combination Products Market: Regional Analysis
Due to the growing recognition and launch of latest products within the region, North America is probably going to led the global drug device combination products market within the foreseeable future. for example, Flowonix Medical, Inc. received USFDA permission in February 2020 for a Prometra II programmable pump system for the employment of intrathecal baclofen. The Prometra II pump uses a pressure-driven, valve-gate delivery system to deliver drug boluses into the intrathecal space.
Europe is an emerging marketplace for drug device combination products because of the increasing rate of chronic disorders like cardiovascular disorder and others. as an example, in 2018, as per a people Heart Foundation (BHF), over 7 million people within the UK suffered from cardiovascular disorder, a total of 3.5 Mn women and 3.5 Mn men. The BHF also states that 26% of all deaths within the UK are due to heart and circulatory disorders, with quite 150,000 deaths every year.
𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/3919
Global Drug Device Combination Products Market: Key Developments
Key players within the market specialise in approving and launching new products to enlarge their product portfolio. as an example, Flowonix Medical, Inc. received USFDA permission in February 2020, for its Prometra II programmable pump system to use intrathecal baclofen. The Prometra II pump uses a pressure-driven, valve-gate delivery system to deliver drug boluses into the intrathecal space.
Key players within the market specialise in adopting partnership strategies to enlarge their product portfolio. as an example, Hasselmeier, a manufacturer of self-injection equipment, partnered with Stevenato Group, a manufacturer of glass primary packaging in Italy in October 2019, to develop, manufacture and provide diabetic care of Ax-D pen-injectors within the therapeutic field.
Global Drug Device Combination Products Market: Segmentation
On the basis of Product Type, the Global Drug Device Combination Products Market is segmented into:
- Drug Eluting Stents
- Coronary Stent
- Peripheral Vascular Stents
- Infusion Pumps
- Implantable
- Ambulatory
- Photosensitizers
- Orthopedic Combination Products
- Wound Care Combination Products
- Inhalers
- Dry Powder Inhaler
- Nebulizers
- Metered Dose Inhaler
On the basis of Distribution Channel, the Global Drug Device Combination Products Market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
On the basis of Region, the Global Drug Device Combination Products Market is segmented into:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Global Drug Device Combination Products Market: Competitive Landscape
Key players performing in the global drug device combination products market are Flowonix Medical Inc., Haselmeier GmbH, Bausch Health Companies Inc., Teleflex Incorporated, Integer Holdings Corporation, Boston Scientific Corporation, Alcon Inc., Dickinson and Company, Becton, SINOMED, Kaleo Inc., Medtronic Plc., Abbott Laboratories, AbbVie Inc., and Teva Pharmaceutical Industries Ltd.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/3919
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Product Launch
- Mergers & Acquisitions Scenario
- Regulatory Scenario
- Reimbursement Scenario
- PEST Analysis
- PORTER’s Analysis
- Market Dynamics
- Global Drug-Device Combination Products Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Supply and Demand Analysis
- Government Initiatives
- Global Drug-device Combination Products Market, By Product Type, 2016 – 2027 (US$ Billion)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Drug Eluting Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Coronary Stent
- Peripheral Vascular Stents
- Infusion Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Implantable
- Ambulatory
- Photosensitizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Orthopedic Combination Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Wound care Combination Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Dry Powder Inhaler
- Nebulizers
- Metered Dose Inhaler
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Introduction
- Global Drug-device Combination Products Market, By Distribution Channel, 2016 – 2027 (US$ Billion)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Billion)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/drug-device-combination-products-market-3188
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837